
Nextgen Healthcare is a health information services business based in the US. Nextgen Healthcare shares (NXGN) are listed on the NASDAQ and all prices are listed in US Dollars. Nextgen Healthcare employs 2,655 staff and has a trailing 12-month revenue of around $613.7 million.
How to buy Nextgen Healthcare stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – NXGN. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
Robinhood
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
tastyworks
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
What's in this guide?
Nextgen Healthcare stock price (NASDAQ: NXGN)
Use our graph to track the performance of NXGN stocks over time.Nextgen Healthcare shares at a glance
Latest market close | $18.82 |
---|---|
52-week range | $16.13 - $21.99 |
50-day moving average | $19.08 |
200-day moving average | $18.46 |
Wall St. target price | $21.19 |
PE ratio | 56.9333 |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $0.30 |
Buy Nextgen Healthcare stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Nextgen Healthcare stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Nextgen Healthcare price performance over time
Historical closes compared with the close of $18.82 from 2023-01-30
1 week (2023-01-25) | 4.15% |
---|---|
1 month (2022-12-30) | 0.21% |
3 months (2022-11-01) | -7.15% |
6 months (2022-08-01) | 8.98% |
1 year (2022-02-01) | -1.83% |
---|---|
2 years (2021-02-01) | -5.28% |
3 years (2020-01-31) | 35.79% |
5 years (2018-01-31) | 44.77% |
Is Nextgen Healthcare stock undervalued or overvalued?
Valuing Nextgen Healthcare stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Nextgen Healthcare's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Nextgen Healthcare's P/E ratio
Nextgen Healthcare's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 57x. In other words, Nextgen Healthcare shares trade at around 57x recent earnings.
That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.
Nextgen Healthcare's PEG ratio
Nextgen Healthcare's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.5624. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Nextgen Healthcare's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Nextgen Healthcare's EBITDA
Nextgen Healthcare's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $34.2 million.
The EBITDA is a measure of a Nextgen Healthcare's overall financial performance and is widely used to measure a its profitability.
Nextgen Healthcare financials
Revenue TTM | $613.7 million |
---|---|
Operating margin TTM | 4.11% |
Gross profit TTM | $332.8 million |
Return on assets TTM | 2.5% |
Return on equity TTM | 4.63% |
Profit margin | 3.31% |
Book value | $6.54 |
Market capitalisation | $1.2 billion |
TTM: trailing 12 months
Nextgen Healthcare share dividends
We're not expecting Nextgen Healthcare to pay a dividend over the next 12 months.
Have Nextgen Healthcare's shares ever split?
Nextgen Healthcare's shares were split on a 2:1 basis on 26 October 2011. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your Nextgen Healthcare shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for Nextgen Healthcare shares which in turn could have impacted Nextgen Healthcare's share price.
Nextgen Healthcare share price volatility
Over the last 12 months, Nextgen Healthcare's shares have ranged in value from as little as $16.13 up to $21.99. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Nextgen Healthcare's is 1.0446. This would suggest that Nextgen Healthcare's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).
Nextgen Healthcare overview
NextGen Healthcare, Inc. provides healthcare technology solutions in the United States. The company offers clinical care solutions, including NextGen Enterprise EHR; financial solutions, such as NextGen Enterprise PM; patient engagement solutions comprising NextGen Virtual Visits; integrated clinical care and financial solutions consisting of NextGen Office; interoperability solutions that include NextGen Share and Mirth Connect; data and analytics solutions, which comprise NextGen Health Data Hub; and value based care solutions, including NextGen Population Health Solutions. It also provides managed services, such as revenue cycle management services comprising billing and collections, electronic claims submission and denials management, electronic remittance and payment posting, and accounts receivable follow-up; and client and support services. Further, the company offers professional services consisting of training, project management, installation services, and application managed services; and consulting services that include physician, professional, and technical consulting; assisting clients to optimize their staffing and software solutions; enhancing financial and clinical outcomes; achieving regulatory requirements; and meeting the requirements of healthcare reform. It serves accountable care organizations, independent physician associations, managed service organizations, veterans service organizations, dental service organizations, ambulatory care centers, and community health centers through a direct sales force and reseller channel. The company was formerly known as Quality Systems, Inc.
Nextgen Healthcare in the news
NextGen Healthcare, Inc. (NASDAQ:NXGN) Q3 2023 Earnings Call Transcript
We Ran A Stock Scan For Earnings Growth And NextGen Healthcare (NASDAQ:NXGN) Passed With Ease
NextGen Healthcare Third Quarter 2023 Earnings: EPS Beats Expectations
Frequently asked questions
What percentage of Nextgen Healthcare is owned by insiders or institutions?Currently 18.684% of Nextgen Healthcare shares are held by insiders and 78.867% by institutions. How many people work for Nextgen Healthcare?
Latest data suggests 2,655 work at Nextgen Healthcare. When does the fiscal year end for Nextgen Healthcare?
Nextgen Healthcare's fiscal year ends in March. Where is Nextgen Healthcare based?
Nextgen Healthcare's address is: Building 6, Atlanta, GA, United States, 30305 What is Nextgen Healthcare's ISIN number?
Nextgen Healthcare's international securities identification number is: US65343C1027 What is Nextgen Healthcare's CUSIP number?
Nextgen Healthcare's Committee on Uniform Securities Identification Procedures number is: 65343C102
More guides on Finder
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
-
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert